NASDAQ:BCRX   BioCryst Pharmaceuticals, Inc.
Favorite stock here. Fundamentals are outstanding. Excited for Q4 earnings and more importantly Q1. Future $100 stock in 5 years if execution on Bero and Factor D follow through.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。